Publications by authors named "Ryan D Gentzler"

28Publications

Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series.

Cardiooncology 2020 23;6:21. Epub 2020 Sep 23.

Department of Medicine, Division of Hematology and Medical Oncology, University of Virginia, PO Box 800716, Charlottesville, VA 22908 USA.

View Article and Find Full Text PDF
September 2020

Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy.

Curr Oncol Rep 2020 Aug 15;22(11):109. Epub 2020 Aug 15.

Division of Thoracic Cardiovascular Surgery, University of Virginia, Charlottesville, VA, USA.

View Article and Find Full Text PDF
August 2020

Epidermal Growth Factor Receptor Mutations.

Thorac Surg Clin 2020 May;30(2):127-136

Division of Hematology/Oncology, University of Virginia School of Medicine, PO Box 800716, Charlottesville, VA 22908, USA. Electronic address:

View Article and Find Full Text PDF
May 2020

Clinical and Radiographic Response of Leptomeningeal and Brain Metastases to Encorafenib and Binimetinib in a Patient With BRAF V600E-Mutated Lung Adenocarcinoma.

J Thorac Oncol 2019 12;14(12):e269-e271

Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address:

View Article and Find Full Text PDF
December 2019

Rapid Response to Pembrolizumab in a Critically Ill Mechanically Ventilated Patient with New Diagnosis of NSCLC.

J Thorac Oncol 2019 09;14(9):e193-e195

Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address:

View Article and Find Full Text PDF
September 2019

Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib.

Clin Lymphoma Myeloma Leuk 2019 06 11;19(6):e247-e250. Epub 2019 Mar 11.

Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.

View Article and Find Full Text PDF
June 2019

Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.

Int J Radiat Oncol Biol Phys 2019 06 11;104(2):436-446. Epub 2019 Feb 11.

Department of Radiation Oncology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address:

View Article and Find Full Text PDF
June 2019

Tyrosine Kinase Inhibition in a Lung Adenocarcinoma Patient With Dual G719S and S768I EGFR Mutations.

J Thorac Oncol 2018 08;13(8):e136-e137

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address:

View Article and Find Full Text PDF
August 2018

Erratum: Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.

J Hematol Oncol 2015 Dec 29;8:131. Epub 2015 Dec 29.

Department of Pathology, Northwestern University Feinberg School of Medicine, Feinberg 7-209A, 251 E. Huron Street, Chicago, IL, 60611, USA.

View Article and Find Full Text PDF
December 2015

Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC).

Transl Lung Cancer Res 2015 Oct;4(5):515-23

1 Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA ; 2 Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, USA.

View Article and Find Full Text PDF
October 2015

Complex decisions for first-line and maintenance treatment of advanced wild-type non-small cell lung cancer.

Oncologist 2015 Mar 6;20(3):299-306. Epub 2015 Feb 6.

Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA; Sarah Cannon Research Institute, Nashville, Tennessee, USA

View Article and Find Full Text PDF
March 2015

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.

Cancer 2014 Dec 25;120(24):3853-8. Epub 2014 Aug 25.

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.

View Article and Find Full Text PDF
December 2014

Optimal first-line and maintenance treatments for advanced-stage nonsquamous non-small cell lung cancer.

J Natl Compr Canc Netw 2014 Jun;12(6):889-97

From the Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.

View Article and Find Full Text PDF
June 2014

Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.

J Hematol Oncol 2014 Apr 22;7:36. Epub 2014 Apr 22.

Department of Pathology, Northwestern University Feinberg School of Medicine, 251 E, Huron Street, Chicago, IL 60611, USA.

View Article and Find Full Text PDF
April 2014

Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications.

Ther Adv Med Oncol 2014 Jan;6(1):4-15

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, 676 North St. Clair, Suite 850. Chicago, IL 60611, USA.

View Article and Find Full Text PDF
January 2014

Bevacizumab in advanced NSCLC: chemotherapy partners and duration of use.

Curr Treat Options Oncol 2013 Dec;14(4):595-609

Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 676 North St. Clair, Suite 850, Chicago, IL, 60611, USA.

View Article and Find Full Text PDF
December 2013

An overview of the mTOR pathway as a target in cancer therapy.

Expert Opin Ther Targets 2012 May 12;16(5):481-9. Epub 2012 Apr 12.

Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center , 303 East Superior Street, Lurie 3-107, Chicago, IL 60611 , USA +1 312 5034267 ; +1 312 9081372 ;

View Article and Find Full Text PDF
May 2012

Complex hypereosinophilia arising from post-polycythemia vera myelofibrosis: A case of imatinib-responsiveness.

Leuk Res Rep 2012 10;1(1):9-12. Epub 2012 Nov 10.

Department of Medicine, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, USA.

View Article and Find Full Text PDF
December 2013